1.
Cui ML, Kim KH, Kim HG, et al. Incidence, risk factors andclinical course of pancreatic fluid collections in acute pancreatitis.Dig Dis Sci. 2014;59(5):1055-1062.
2.
Guzmán-Calderón E, Diaz-Arocutipa C, Monge E. Lactateringer’s versus normal saline in the management of acutepancreatitis: a systematic review and meta-analysis of randomizedcontrolled trials. Dig Dis Sci. 2022;67(8):4131-4139.
3.
Heckler M, Hackert T, Hu K, Halloran CM, Büchler MW,Neoptolemos JP. Severe acute pancreatitis: surgical indicationsand treatment. Langenbecks Arch Surg. 2021;406(3):521-535.
4.
Matta B, Gougol A, Gao X, et al. Worldwide variations indemographics, management, and outcomes of acute pancreatitis.Clin Gastroenterol Hepatol. 2020;18(7):1567-1575.
5.
Diculescu M, Ciocîrlan M, Ciocîrlan M, Stanescu D,Ciprut T, Marinescu T. Predictive factors for pseudocystsand peripancreatic collections in acute pancreatitis. Rom JGastroenterol. 2005;14(2):129-134.
6.
Poornachandra KS, Bhasin DK, Nagi B, et al. Clinical, biochemical,and radiologic parameters at admission predicting formationof a pseudocyst in acute pancreatitis. J Clin Gastroenterol.2011;45(2):159-163.
7.
Banks PA, Bollen TL, Dervenis C, et al. Acute PancreatitisClassification Working Group. classification of acutepancreatitis-2012: revision of the Atlanta classification anddefinitions by international consensus. Gut. 2013;62(1):102-111.
8.
Eguchi T, Tsuji Y, Okada A, et al. Reducing the risk of developingwalled-off necrosis in patients with acute necrotic collection usingrecombinant human soluble thrombomodulin. J HepatobiliaryPancreat Sci. 2021;28(9):788-797.
9.
Iannuzzi JP, King JA, Leong JH, et al. Global incidence of acutepancreatitis is increasing over time: a systematic review andmeta-analysis. Gastroenterol. 2022;162(1):122-134.
10.
Tan JH, Zhou L, Cao RC, Zhang GW. Identification of riskfactors for pancreatic pseudocysts formation, intervention andrecurrence: a 15-year retrospective analysis in a tertiary hospitalin China. BMC Gastroenterology. 2018;18(1):143.
11.
Manrai M, Kochhar R, Gupta V, et al. Outcome of acutepancreatic and peripancreatic collections occurring in patientswith acute pancreatitis. Ann Surg. 2018;267(2):357-363.
12.
Stamatakos M, Stefanaki C, Kontzoglou K, Stergiopoulos S,Giannopoulos G, Safioleas M. Walled-off pancreatic necrosis.World J Gastroenterol. 2010;16(14):1707-1712.
13.
Ramia JM, de la Plaza R, Quiñones-Sampedro JE, Ramiro C,Veguillas P, García-Parreño J. Walled-off pancreatic necrosis.Neth J Med. 2012;70(4):168-171.
14.
Akgül Ö, Ersöz Ş, Şenol K, Gündoğdu SB, Çetinkaya E, Tez M.Calcium level may be a predictive factor for pseudocyst formationafter acute pancreatitis. Acta Gastroenterol Belg. 2015;78(2):219-222.
15.
Lin CT, McKenzie M, Pell J, Caplan L. Hypertriglyceridemia andacute pancreatitis. JAMA Inter Med. 2013;173(2):160-162.
16.
Carr RA, Rejowski BJ, Cote GA, Pitt HA, Zyromski NJ. Systematicreview of hypertriglyceridemia-induced acute pancreatitis: amore virulent etiology? Pancreatol. 2016;16(4):469-476.
17.
Frick TW. The role of calcium in acute pancreatitis. Surg.2012;152(3):157-163.
18.
Valverde-López F, Matas-Cobos AM, Alegría-Motte C, Jiménez-Rosales R, Úbeda-Muñoz M, Redondo-Cerezo E. BISAP,RANSON, lactate and others biomarkers in prediction of severeacute pancreatitis in a European cohort. J Gastroenterol Hepatol.2017;32(9):1649-1656.
19.
Lallès JP. Recent advances in intestinal alkaline phosphatase,inflammation, and nutrition. Nutr Rev. 2019;77(10):710-724.
20.
Fawley J, Gourlay DM. Intestinal alkaline phosphatase: a summaryof its role in clinical disease. J Surgic Res. 2016;202(1):225-234.
21.
Yarkaç A, Kose A, Bozkurt Babuş S, Ates F, Orekici Temel G,Ölmez A. Akut pankreatitte hematolojik parametrelerin değeri.Ulus Travma Acil Cerrahi Derg. 2019;25(5):453-460.
22.
Kong W, He Y, Bao H, Zhang W, Wang X. Diagnostic valueof neutrophil-lymphocyte ratio for predicting the severityof acute pancreatitis: a meta-analysis. Disease Markers.2020;2020:9731854.
23.
Kaplan M, Ates I, Oztas E, et al. A new marker to determineprognosis of acute pancreatitis: PLR and NLR combination. JMed Biochemis. 2018;37(1):21-30.
24.
Dancu GM, Popescu A, Sirli R, et al. The BISAP score, NLR,CRP, or BUN: which marker best predicts the outcome of acutepancreatitis? Medicine. 2021;100(51):E28121.
25.
Cho SK, Jung S, Lee KJ, Kim JW. Neutrophil to lymphocyteratio and platelet to lymphocyte ratio can predict the severity ofgallstone pancreatitis. BMC Gastroenterol. 2018;18(1):18.
26.
Werner J, Hartwig W, Uhl W, Müller C, Büchler MW. Usefulmarkers for predicting severity and monitoring progression ofacute pancreatitis. pancreatology. Elsevier B V. 2003;3(2):115-127.
27.
Kandasamy S. Is it all clear if procalcitonin clears in acutepancreatitis? Indian J Critic Care Med. 2020;24(3):149-150.
28.
Clyne B, Olshaker JS. The C-reactive protein. J Emerg Med.1999;17(6):1019-1025.
29.
Stirling AD, Moran NR, Kelly ME, Ridgway PF, Conlon KC. Thepredictive value of C-reactive protein (CRP) in acute pancreatitis- is interval change in CRP an additional indicator of severity?HPB. 2017;19(10):874-880.
30.
Vinish DB, Abishek V, Sujatha K, Arulprakash S, Solomon R,Ganesh P. Role of bedside pancreatic scores and C-reactiveprotein in predicting pancreatic fluid collections and necrosis.Indian J Gastroenterol. 2017;36(1):43-49.
31.
Bozkurt E, Muhafiz E, Sengul D, Uçak T, Atum M. Can the CRP/albumin ratio be used as a new indicator of activation in patientswith uveitis? Ocular Immun Inflammat. 2021;29(5):1017-1022.
32.
Gibson DJ, Hartery K, Doherty J, et al. CRP/Albumin ratio: anearly predictor of steroid responsiveness in acute severe ulcerativecolitis. J Clin Gastroenterol. 2018;52(6):48-52.
33.
Kaplan M, Ates I, Akpinar MY, et al. Predictive value ofC-reactive protein/albumin ratio in acute pancreatitis. HepatobilPancr Diseas Int. 2017;16(4):424-430.
34.
Yılmaz EM, Kandemir A. Significance of red blood celldistribution width and c-reactive protein/albumin levels inpredicting prognosis of acute pancreatitis. Ulus Trav Acil CerrahiDerg. 2018;24(6):528-531.